U.S. RESEARCH ROUNDUP- aTyr pharma, Clear Secure, Neumora Therapeutics
Sept 16 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including aTyr pharma, Clear Secure and Neumora Therapeutics on Tuesday.
HIGHLIGHTS
* aTyr pharma Inc ATYR.O: RBC cuts to sector perform from outperform |
* Clear Secure Inc YOU.N: D.A. Davidson initiates coverage with buy rating |
* Neumora Therapeutics Inc NMRA.O: JP Morgan cuts to underweight from neutral |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* Alnylam Pharmaceuticals Inc ALNY.O: Jefferies raises target price to $550 from $453 |
* Atlanticus Holdings Corp ATLC.O: Jefferies raises target price to $85 from $70 |
* aTyr pharma Inc ATYR.O: H.C. Wainwright cuts to neutral from buy |
* aTyr pharma Inc ATYR.O: Jefferies cuts target price to $3 from $17 |
* aTyr pharma Inc ATYR.O: RBC cuts to sector perform from outperform |
* aTyr pharma Inc ATYR.O: RBC cuts target price to $1.50 from $16 |
* California Resources CRC.N: Gerdes Energy Research raises target price by $8 to $67 |
* California Resources CRC.N: TD Cowen raises target price to $68 from $65 |
* California Resources CRC.N: Texas Capital Securities raises PT to $73.00 from $69.00 |
* Camp4 Therapeutics Corp CAMP.O: JP Morgan cuts to neutral from overweight |
* Carmax Inc KMX.N: Stephens cuts target price to $74 from $81 |
* Charles Schwab Corp SCHW.N: Deutsche Bank cuts target price to $113 from $114 |
* Chord Energy Corp CHRD.O: Piper Sandler raises target price to $169 from $166 |
* Cipher Mining Inc CIFR.O: Canaccord Genuity raises target price to $13 from $9 |
* Clear Secure Inc YOU.N: D.A. Davidson initiates coverage with buy rating |
* Clear Secure Inc YOU.N: D.A. Davidson initiates coverage with price target $45 |
* Coda Octopus Group Inc CODA.O: Alliance Global Partners raises PT to $11 from $10 |
* Dave & Buster'S Entertainment Inc PLAY.O: Piper Sandler cuts PT to $26 from $30 |
* Kymera Therapeutics Inc KYMR.O: RBC initiates coverage with outperform rating |
* Kymera Therapeutics Inc KYMR.O: RBC initiates coverage with price target $70 |
* Neumora Therapeutics Inc NMRA.O: JP Morgan cuts to underweight from neutral |
* Ross Stores Inc ROST.O: Jefferies raises target price to $175 from $170 |
* Strategy MSTR.O: TD Cowen cuts target price to $620 from $640 |
* Warner Bros Discovery Inc WBD.O: TD Cowen cuts to hold from buy rating |
Related Articles
Effects of Interest Rate Cuts: Impact of Fed's September Meeting on Crypto Market
The Fed’s rate cut decision is a major bullish catalyst for crypto — but it comes with uncertainty. Investors should understand the economic rationale behind the move and adjust strategies accordingly. Staying flexible, informed, and disciplined is key to thriving in crypto’s fast-moving environment
September Global Central Bank Divergence: How Will U.S. Stocks and Forex Markets Move?
TradingKey - Despite the divergence in monetary policies among major global central banks in September (with the Federal Reserve cutting rates while the European Central Bank, Bank of England, and Bank of Japan maintain steady rates), we expect the policy directions of the Fed, ECB, and BoE to...
U.S. September Rate Decision Preview: What It Means for Bitcoin and Could It Spark a New Rally?
Bitcoin’s rally stalls ahead of the Fed meeting — has the bullish momentum already been priced in?
Japan Q2 GDP Commentary: Growth Revised Upward, Yen May Rise
TradingKey - On 8 September 2025, Japan released the revised Q2 GDP figures. The data showed that real GDP grew by 0.5% quarter-on-quarter, surpassing market expectations of 0.3% and the previous quarter’s 0% growth.
Fed to Cut Rates: All Asset Prices Up!
TradingKey - The Federal Reserve is almost certain to restart its interest rate cut cycle on 17 September this year. After in-depth research, we have concluded that cryptocurrencies, the broader U.S. stock market, and short-term U.S. Treasury bonds will all go up.
